← Leaderboards
Michael A Thomas
Wake Forest University Health Sciences
$604,761
Attributed
$604,761
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2005–17$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$604,761 · 2
By mechanism
R00$498,000 · 1
F31$106,761 · 1
Top collaborators
No co-investigators on record.
Most similar at Wake Forest University Health Sciences
Same institution · by research overlap
- Merideth A. Addicott$5,348,314
- Keith L Keene$1,520,920
- David Arnold Ornelles$5,031,983
- Josyf Mychaleckyj$1,142,418
- Elizabeth J Glover$6,053,062
Others in their field
Top investigators on “Cell Cycle”
- Bruce W Stillman · Cold Spring Harbor Laboratory$87,228,479
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Nevan J Krogan · University Of California, San Francisco$83,822,021
- Mary M Horowitz · Medical College Of Wisconsin$76,714,344
- Frank Patrick McCormick · University Of California San Francisco$75,259,666
- David Heimbrook · Leidos Biomedical Research, Inc.$68,555,131
Research focus
Cell CycleDna DamageAntibodiesCytokineAdjuvantAdenovirusesAcquired Immunodeficiency SyndromeCell TypeAdenovirus VectorCultured CellsAttenuated Live Virus VaccineAttributable MortalityAffectBiochemicalCessation Of LifeB-LymphocytesAdenovirus ProteinCarrying CapacitiesCell CommunicationDesignAntigensCell LineCellsDose
Grant awards (5)
Effective Replicating Adenovirus-HIV Vaccines$249,000
R00 · FY2017 · AI · contact PI
Effective Replicating Adenovirus-HIV Vaccines$249,000
R00 · FY2016 · AI · contact PI
Translational control by an oncolytic adenovirus$25,412
F31 · FY2006 · CA · contact PI
Translational control by an oncolytic adenovirus$41,042
F31 · FY2005 · CA
Translational control by an oncolytic adenovirus$40,307
F31 · FY2004 · CA